Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Vanguard Health Care ETF (NY:VHT)

242.63 -1.65 (-0.68%)
Streaming Delayed Price Updated: 10:14 AM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanguard Health Care ETF

< Previous 1 2 3 Next >
7 Great ETFs to Buy Now for Momentum in Q2
These seven ETFs to buy are among the best funds. YPS, BITQ, FMET, QQMG, DVY, XSD, and VHT can make excellent investments. 
Via InvestorPlace
Rebalanced ESG ETFs Index down 6.9% YTD
ESG funds did better than the broader market during the stock volatility surrounding the coronavirus pandemic. 
Via Talk Markets
2 ETFs to Watch for Outsized Volume on Healthcare and Mid-Cap
Both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if... 
Via Talk Markets
5 Safe ETF Bets To Consider After A Dull Market Last Week
The healthcare sector is a good defensive investment option as several investors believe consumers will have to purchase healthcare products even during tough and uncertain times. 
Via Talk Markets
3 Vanguard ETFs to Buy Now
These are the best long-term Vanguard ETFs to invest in now. VUG, VHT, and VIOV can make great investments in April. 
Via InvestorPlace
5 ETF Areas for Investors to Consider Amid the September Slump
Wall Street is witnessing a tough time in the historically weak month of September. 
Via Talk Markets
Healthcare ETFs in Focus as Q2 Earnings Unfold
Let’s dig deeper into the earnings picture of the companies which will drive the performance of healthcare funds in the coming days. 
Via Talk Markets
Healthcare ETFs on Radar As Q1 Earnings Unfold
The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come. 
Via Talk Markets
Exposures COVID-19
Why Bristol Myers Squibb Deserves a Place in Your Portfolio
This undervalued pharmaceutical is a great buy in 2021. 
Via The Motley Fool
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.